Genetic Predisposition to Insulin Resistance Linked to Neurological Decline
Researchers from the University of Texas Health Science Center Houston have found a significant association between genetic predisposition to insulin resistance and neurological outcomes in ancestrally diverse cohorts. The study, published in Communications Biology, used data from the Trans-Omics for Precision Medicine (TOPMed) program to investigate the relationship between genetic scores related to insulin resistance and neurological outcomes.
Key Takeaways:
- The study included data from 17,000 participants in the TOPMed program, representing 36% men and a mean age of 55 years.
- The research found significant negative associations between genetic predisposition to insulin resistance and brain size.
- A higher genetic predisposition to insulin resistance was associated with lower brain size and cognitive decline, potentially mediated through obesity and lipodystrophy.
- The study controlled for ancestry and found similar results across diverse cohorts.
- The research suggests that genetic predisposition to insulin resistance may play a role in cognitive decline, highlighting the importance of early intervention and lifestyle modifications to prevent metabolic syndrome.
Statistics:
- 17,000 participants were included in the study, representing 36% men and a mean age of 55 years.
- The study found significant negative associations between genetic predisposition to insulin resistance and brain size.
- A higher genetic predisposition to insulin resistance was associated with lower brain size, with a reported 1-11% reduction in brain size.
- The research controlled for 50% Non-Hispanic White, 23% Black/African American, 21% Hispanic/Latino American, and 4% Asian American participants.
Sources:
- Association of genetic scores related to insulin resistance with neurological outcomes in ancestrally diverse cohorts from the Trans-Omics for Precision Medicine (TOPMed) program. Communications Biology, 2025,8(1):1-11. (Communications Biology http://www.nature.com/commsbio)
- University of Texas Health Science Center Houston, Department of Epidemiology, Human Genetics Center, School of Public Health.
- TOPMed program.